Paper · 11372012
Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.
Hróbjartsson A and 1 other. N Engl J Med, 2001. Cited by 1,009 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. Papers, record 11372012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11372012
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Placebo Effect | Major topic |
| Placebos | Major topic |
| Anxiety | |
| Asthma | |
| Confidence Intervals | |
| Depression | |
| Empirical Research | |
| Hypertension | |
| Nausea | |
| Obesity | |
| Pain Management | |
| Randomized Controlled Trials as Topic | |
| Risk | |
| Sensitivity and Specificity | |
| Sleep Initiation and Maintenance Disorders | |
| Smoking Cessation | |
| Treatment Outcome |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections6
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 11,372,013 | Clinical practice. Current approaches to cervical-cancer screening. | https://conductscience.org/library/papers/11372013 | PubMed |
| Comment in | 11,372,017 | The powerful placebo and the Wizard of Oz. | https://conductscience.org/library/papers/11372017 | PubMed |
| Comment in | 11,680,452 | Is the placebo powerless? | https://conductscience.org/library/papers/11680452 | PubMed |
| Comment in | 11,680,453 | Is the placebo powerless? | https://conductscience.org/library/papers/11680453 | PubMed |
| Comment in | 11,829,561 | Review: placebo is better than no treatment for subjective continuous outcomes and for treatment of pain. | https://conductscience.org/library/papers/11829561 | PubMed |
| Comment in | 11,915,818 | Review: placebo is better than no treatment for subjective continuous outcomes and for treatment of pain. | https://conductscience.org/library/papers/11915818 | PubMed |
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by330
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,009 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,390,710 | Effect of Probiotic Supplementation in Older Individuals with Mild Cognitive Impairment and Alzheimer's Disease: A Randomized, Placebo-Controlled, Triple-Blind Clinical Trial. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/42390710 | PubMed |
| 42,104,173 | Supply and Demand in the Mathematics of Rare Disease Drug Development: Why Choosing the Right Model Is Crucial. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42104173 | PubMed |
| 42,056,755 | The Placebo Effect in Rare Disease Clinical Trials: Measurement, Impact, and Statistical Approaches for Patient-as-Own-Control Designs. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42056755 | PubMed |
| 41,997,697 | Measuring and appraising placebo effects in clinical trials: contemporary challenges and approaches in psychiatry. | Lancet Psychiatry | 2026 | https://conductscience.org/library/papers/41997697 | PubMed |
| 41,898,179 | Reconsidering Placebo Effects in Neuromodulation for Parkinson's Disease: Lessons for Clinical Trials and Therapeutic Translation. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898179 | PubMed |
| 41,807,766 | Cure as medicine's constitutive aim: a defence of the refined curative thesis. | Med Health Care Philos | 2026 | https://conductscience.org/library/papers/41807766 | PubMed |
| 41,402,551 | Neurofeedback, Biofeedback, and Basic Learning Theory: Revisiting the 2011 Conceptual Framework. | Appl Psychophysiol Biofeedback | 2026 | https://conductscience.org/library/papers/41402551 | PubMed |
| 41,048,668 | Surgery for pineal cysts with symptoms in the absence of hydrocephalus: a prospective cohort study. | EClinicalMedicine | 2025 | https://conductscience.org/library/papers/41048668 | PubMed |
| 40,906,977 | Safety and Efficacy of Perispinal Etanercept for Chronic Stroke: A Randomized Clinical Trial. | Neurology | 2025 | https://conductscience.org/library/papers/40906977 | PubMed |
| 40,721,322 | Isolating Brain Mechanisms of Expectancy Effects on Pain: Cue-Based Stimulus Expectancies versus Placebo-Based Treatment Expectancies. | J Neurosci | 2025 | https://conductscience.org/library/papers/40721322 | PubMed |
1 to 10 of 330
See all 330 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11372012
GET https://conductscience.org/api/papers/v1/11372012/cited_by?page=2